<%@ Page Title="" Language="C#" MasterPageFile="~/masterpages/module.master" AutoEventWireup="true" CodeFile="references-nl.aspx.cs" Inherits="secure_modules_module2_references_nl" %>

<asp:Content ID="Content1" ContentPlaceHolderID="contentBreadcrumb" Runat="Server">
     Klinische Presentatie \ Alle referenties
</asp:Content>
<asp:Content ID="Content2" ContentPlaceHolderID="contentSideBar" Runat="Server">
</asp:Content>
<asp:Content ID="Content3" ContentPlaceHolderID="contentMain" Runat="Server">
     <div class="module2page">
        <h1>
            Alle referenties</h1>
            <div class="icon_reading">
        <ul class="references">
            <li><span> Hauser SL, Goodin SC. Multiple sclerosis and other demyelinating diseases. Chapter 375 in: Harrison’s Principles of Internal Medicine. 17th ed. New York, NY: McGraw-Hill; 2008.</span></li> 

            <li><span> Miller D, Barkhof F, Montalban X, <i>et al.</i> Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. <i>Lancet Neurol</i> 2005; 4(5): 281–8.</span></li> 

            <li><span> Thrower BW. Clinically isolated syndromes: Predicting and delaying multiple sclerosis. <i>Neurology</i> 2007; 68(24 Suppl 4): S12–15.</span></li> 

            <li><span> Lövblad KO, Anzalone N, Dörfler A, <i>et al.</i> MR imaging in multiple sclerosis: review and recommendations for current practice. <i>AJNR Am J Neuroradiol</i> 2010; 31(6): 983–9.</span></li> 

            <li><span> Polman CH, Reingold SC, Banwell B, <i>et al.</i> Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. <i>Ann Neurol</i> 2011; 69(2): 292–302.</span></li> 

            <li><span> Shaw C, Chapman C, Butzkueven H. How to diagnose multiple sclerosis and what are the pitfalls. <i>Intern Med J</i> 2009; 39(12): 792–9.</span></li> 

            <li><span> Morris Z, Whiteley WN, Longstreth WT Jr, <i>et al.</i> Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. <i>BMJ</i> 2009; 339: b3016. </span></li> 

            <li><span> Sellner J, Schirmer L, Hemmer B, <i>et al.</i> The radiologically isolated syndrome: take action when the unexpected is uncovered? <i>J Neurol</i> 2010; 257(10): 1602–11.</span></li> 

            <li><span>  Okuda DT, Mowry EM, Beheshtian A, <i>et al.</i> Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. <i>Neurology</i> 2009; 72(9): 800–5.</span></li> 

            <li><span>  
                Spain R, Bourdette D. The radiologically isolated syndrome: look (again) before you treat. <i>Curr Neurol Neurosci Rep</i> 2011; 11(5): 498–506.</span></li> 

            <li><span>  Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. <i>Neurology</i> 1996; 46(4): 907–11.</span></li> 

            <li><span>  Sellebjerg F, Barnes D, Filippini G, <i>et al.</i> EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. <i>Eur J Neurol</i> 2005; 12(12): 939–46.</span></li> 

            <li><span>  Murray TJ.  Diagnosis and treatment of multiple sclerosis. <i>BMJ</i> 2006; 332(7540): 525–7.</span></li> 

            <li><span>  Lublin F. Predicting the Course of Multiple Sclerosis: Implications for Treatment. 
                <i>Medscape Education Neurology & Neurosurgery </i>2011.</span></li> 

            <li><span>  Barnes D. Multiple Sclerosis. Questions and Answers. UK Merit Publishing International; 2000.</span></li> 

            <li><span>  Weinshenker BG. The natural history of multiple sclerosis. <i>Neurol Clin</i>1995; 13(1): 119–146.</span></li> 

            <li><span>  Scalfari A, Neuhaus A, Degenhardt A, <i>et al.</i> The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. <i>Brain </i> 2010; 133(Pt 7): 1914–29.</span></li> 

            <li><span>  Tremlett H, Yinshan Zhao, Devonshire V. Natural history of secondary-progressive multiple sclerosis. <i>Mult Scler </i> 2008; 14(3): 314–24.</span></li> 

            <li><span>  Confavreux C. The natural history of multiple sclerosis. Chapter 2 in: Compston A, Confavreux C, Lassmann H, <i>et al.</i> McAlpine’s Multiple Sclerosis. 4th ed. London: Churchill Livingstone; 2006.</span></li> 

            <li><span>  Weinshenker BG, Rice GP, Noseworthy JH, <i>et al.</i> The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. <i>Brain </i> 1991; 114(Pt 2): 1045–56.</span></li> 

            <li><span>  Wehman-Tubbs K, Yale SH, Rolak LA. Insight into multiple sclerosis. <i>Clin Med Res</i> 2005; 3(1): 41–4.</span></li> 

            <li><span>  Weinshenker BG, Bass B, Rice GP, <i>et al.</i> The natural history of multiple sclerosis: a geographically based study. 1: Clinical course and disability. <i>Brain </i> 1989; 112(Pt 1):133–46.</span></li> 

            <li><span>  Marieb EN. Essentials of Human Anatomy and Physiology. 8th ed. San Francisco, CA: Pearson Benjamin Cummings; 2006.</span></li> 

            <li><span>  Cohen and Rudick. Multiple Sclerosis Therapeutics. Informa Healthcare, 2007.</span></li> 

            <li><span>  Halper J, Holland N. An overview of multiple sclerosis: implications for nursing practice. In: Halper J, Holland N, eds. Comprehensive Nursing Care in Multiple Sclerosis. 2nd ed. New York, NY: Demos Medical Publishing; 2002: 1–14.</span></li> 

            <li><span>  Burgess M. Shedding greater light on the natural history and prevalence of multiple sclerosis: a nurse-led model. <i>Br J Neurosci Nursing 2010</i>; 6(1): 7–11.</span></li> 

            <li><span>  Hemmett L, Holmes J, Barnes M, <i>et al.</i> What drives quality of life in multiple sclerosis? <i>QJM</i> 2004; 97(10): 671–6.</span></li> 

            <li><span>  Barnett R. Fatigue. <i>Lancet</i> 2005; 366(9479): 21.</span></li> 

            <li><span>  Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. <i>Mult Scler </i> 2006; 12(4): 367–8.</span></li> 

            <li><span>  Lerdal A, Celius EG, Krupp L, <i>et al.</i> A prospective study of patterns of fatigue in multiple sclerosis. <i>Eur J Neurol</i> 2007; 14(12): 1338–43.</span></li> 

            <li><span>  Brown JN, Howard CA, Kemp DW. Modafinil for the treatment of multiple sclerosis-related fatigue. <i>Ann Pharmacother</i> 2010; 44(6): 1098–103.</span></li> 

            <li><span>  Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. <i>Adv Ther</i> 2009; 26(12): 1043–57.</span></li> 

            <li><span>  Rosenberg JH, Shafor R. Fatigue in multiple sclerosis: a rational approach to evaluation and treatment. <i>Curr Neurol Neurosci Rep</i> 2005; 5(2): 140–6.</span></li> 

            <li><span>  Mollaoğlu M and Ustün E.  Fatigue in multiple sclerosis patients. <i>J Clin Nurs</i> 2009; 18(9): 1231–8.</span></li> 

            <li><span>  Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. <i>J Neurol Sci</i> 2009; 277(Suppl 1): S37–41.</span></li> 

            <li><span>  Zwibel HL and Smrtka J. Improving quality of life in multiple sclerosis: an unmet need. <i>Am J Manag Care</i> 2011; 17 Suppl 5 Improving: S139–45.</span></li> 

            <li><span>  Mitchell AJ, Benito-León J, González JM, <i>et al.</i> Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. <i>Lancet Neurol</i> 2005; 4(9): 556–66.</span></li> 

            <li><span>  Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. <i>Neurology</i> 2000; 55(7): 934–9.</span></li> 

            <li><span>  Kinsinger SW, Lattie E, Mohr DC. Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis. <i>Neuropsychology</i> 2010; 24(5): 573–80.</span></li> 

            <li><span>  Bol Y, Smolders J, Duits A, <i>et al.</i> Fatigue and heat sensitivity in patients with multiple sclerosis. <i>Acta Neurol Scand</i> 2012 Mar 8. Epub ahead of print.</span></li> 

            <li><span> Flensner G, Ek A, Söderhamn O, <i>et al.</i> Sensitivity to heat in MS patients: a factor strongly influencing symptomology – an explorative survey. <i>BMC Neurol</i> 2011, 11: 27.</span></li> 

            <li><span> Bamer AM, Johnson KL, Amtmann D, <i>et al.</i> Prevalence of sleep problems in individuals with multiple sclerosis. <i>Mult Scler</i> 2008; 14(8): 1127–30.</span></li> 

            <li><span> Multiple Sclerosis Information for Health and Social Care Professionals. MS Trust, 4th edition; 2011</span></li> 

            <li><span> Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. <i>Qual Life Res</i> 2001; 10(4): 331–45.</span></li> 

            <li><span> Merlino G, Fratticci L, Lenchig C, <i>et al.</i> Prevalence of ‘poor sleep’ among patients with multiple sclerosis: an independent predictor of mental and physical status. <i>Sleep Med</i> 2009; 10(1): 26–34.</span></li> 

            <li><span> Trojan DA, Kaminska M, Bar-Or AA, et al. Polysomnographic measures of disturbed sleep are associated with reduced quality of life in multiple sclerosis. <i>J Neurol Sci</i> 2012; 316(1–2); 158–63.</span></li> 

            <li><span> Kaminska M, Kimoff RJ, Schwartzman K, <i>et al.</i> Sleep disorders and fatigue in multiple sclerosis: Evidence for association and interaction. <i>J Neurol Sci</i> 2011; 302(1–2): 7–13.</span></li> 

            <li><span> Bamer AM, Johnson KL, Amtmann DA, <i>et al.</i> Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis. <i>Clin Epidemiol</i> 2010; 2010(2): 99–106.</span></li> 

            <li><span> Ma SL, Shea JA, Galetta SL, <i>et al.</i> Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS - specific vision questionnaire. <i>Am J Ophthamol</i> 2002; 133(5): 686–92.</span></li> 

            <li><span> Hickman SJ, Dalton CM, Miller DH, <i>et al.</i> Management of acute optic neuritis. <i>Lancet</i> 2002; 360: 1953−62.</span></li> 

            <li><span> 
                Sakai RE, Feller DJ, Galetta KM, <i>et al.</i> Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. <i>J Neuroophthalmol</i> 2011; 31(4): 362−73.</span></li> 

            <li><span> Foroozan RM, Buono LM, Savino PJ, <i>et al.</i> Acute demyelinating optic neuritis. <i>Curr Opin Ophthalmol</i> 2002; 13(6): 375−80.</span></li> 

            <li><span> Shams PN, Plant GT. Optic neuritis: a review. <i>Int MS J</i> 2009; 16(3):82−9.</span></li> 

            <li><span> Alusi SH, Worthington J, Glickman S, <i>et al.</i> A study of tremor in multiple sclerosis. <i>Brain</i> 2001; 124(Pt 4): 720−30.</span></li> 

            <li><span> Feys PG, Davies-Smith A, Jones R <i>et al.</i> Intention tremor rated according to different finger-to-nose test protocols: a survey. <i>Arch Phys Med Rehabil</i> 2003; 84(1): 79−82.</span></li> 

            <li><span> Feys P, Helsen WF, Liu X, <i>et al.</i> 
                Interaction between eye and hand movements in multiple sclerosis patients with intention tremor. <i>Mov Disord</i> 2005; 20(6): 705−13.</span></li> 

            <li><span> Koch M, Mostert J, Heersema D, <i>et al.</i> Tremor in multiple sclerosis. <i>J Neurol</i> 2007; 254(2): 133–45.</span></li> 

            <li><span> 
                McCombe PA, Gordon TP, Jackson MW. Bladder dysfunction in multiple sclerosis. <i>Expert Rev Neurother</i> 2009; 9(3): 331−40.</span></li> 

            <li><span> DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. <i>Drugs</i> 2003; 63(2): 153−66.</span></li> 

            <li><span> 
               Panicker J, Haslam C. Lower urinary tract dysfunction in MS: management in the community. <i>Br J Community Nurs</i> 2009;14(11): 474−80.</span></li> 

            <li><span> 
               Araki I, Matsui M, Ozawa K, <i>et al.</i> Relationship of bladder dysfunction to lesion site in multiple sclerosis. <i>J Urol</i> 2003; 169(4): 1384−7.</span></li> 

            <li><span> Joseph AC, Albo M. Urodynamics: the incidence of urinary tract infection and autonomic dysreflexia in a challenging population. <i>Urol Nurs</i> 2004; 24(5): 390−3.</span></li> 

            <li><span> Wiesel PH, Norton C, Glickman S, <i>et al.</i> Pathophysiology of bowel dysfunction in multiple sclerosis. <i>Eur J Gastroenterol Hepatol</i> 2001; 13(4): 441−8.</span></li> 

            <li><span> Bywater A, While, A. Management of bowel dysfunction in people with multiple sclerosis. <i>Br J Community Nurs</i> 2006; 11(8): 333−41.</span></li> 

            <li><span> 
                Peppas G, Alexiou VG, Mourtzoukou E, <i>et al.</i> Epidemiology of constipation in Europe and Oceania: a systematic review. <i>BMC Gastroenterol</i> 2008; 8: 5.</span></li> 

            <li><span> 
                Kessler TM, Fowler CJ, Panicker JN. Sexual dysfunction in multiple sclerosis. <i>Expert Rev Neurother</i> 2009; 9(3): 341−50.</span></li> 

            <li><span> 
                Fraser C, Mahoney J, McGurl J. Correlates of sexual dysfunction in men and women with multiple sclerosis. <i>J Neurosci Nurs</i> 2008; 40(5) :312−7.</span></li> 

            <li><span> Tepavcevic DK, Kostic J, Basuroski ID, <i>et al.</i> 
                The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. <i>Mult Scler</i> 2008; 14(8): 1131−6.</span></li> 

            <li><span> Zorzon M, Zivadinov R, Monti Bragadin L, <i>et al.</i> Sexual dysfunction in multiple sclerosis: a 2 year follow up study. <i>J Neurol Sci</i> 2001: 187(1-2): 1–5.</span></li> 

            <li><span> Demirkiran M, Sarica Y, Uguz S, <i>et al.</i> Multiple sclerosis patients with and without sexual dysfunction: are there any differences? <i>Mult Scler</i> 2006; 12(2): 209–14.</span></li> 

            <li><span> 
                Fletcher SG, Castro-Borrero W, Remington G, <i>et al.</i> Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. <i>Nat Clin Pract Urol</i> 2009; 6(2): 96−107.</span></li> 

            <li><span> Darley FL, Brown JR, Goldstein NP. Dysarthria in multiple sclerosis. <i>J Speech Hear Res</i> 1972; 15(2): 229–45.</span></li> 

            <li><span> Brown SA. Swallowing and speaking: challenges for the MS patient. <i>Int J MS Care</i> 2000; 2(3): 7−13.</span></li> 

            <li><span> Hartelius L, Runmarker B, Andersen O. Prevalence and characteristics of dysarthria in a multiple-sclerosis incidence cohort: relation to neurological data. <i>Folia Phoniatr Logop</i> 2000; 52(4): 160−77.</span></li> 

            <li><span> 
                Tassorelli C, Bergamaschi R, Buscone S, et al. Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. <i>Neurol Sci</i> 2008; 29 Suppl 4: S360−3.</span></li> 

            <li><span> Calcagno P, Ruoppolo G, Grasso MG, <i>et al.</i> Dysphagia in multiple sclerosis - prevalence and prognostic factors. <i>Acta Neurol Scand</i> 2002; 105(1): 40−3.</span></li> 

            <li><span> 
                Poorjavad M, Derakhshandeh F, Etemadifar M, <i>et al.</i> Oropharyngeal dysphagia in multiple sclerosis. <i>Mult Scler</i> 2010; 16(3): 362−5.</span></li> 

            <li><span> 
             De Pauw A, Dejaeger E, D'hooghe B, <i>et al.</i> Dysphagia in multiple sclerosis. <i>Clin Neurol Neurosurg</i> 2002; 104(4): 345−51.</span></li> 

            <li><span> Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. <i>Nat Rev Neurol</i> 2011; 7(6): 332−42.</span></li> 

            <li><span> Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. <i>Lancet Neurol</i> 2008; 7(12): 1139−51.</span></li> 

            <li><span> Gingold J. Facing the cognitive challenges of multiple sclerosis. 2nd ed. New York: Demos; 2011.</span></li> 

            <li><span> Amato MP, Zipoli V. Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence. <i>Int MS J</i> 2003; 10(3): 72−83.</span></li> 

            <li><span> Cohen BA. Identification, causation, alleviation, and prevention of complications (ICAP). An approach to symptom and disability management in multiple sclerosis. <i>Neurology</i> 2008; 71(24 Suppl 3): S14−20.</span></li> 

            <li><span> National Multiple Sclerosis Society (NMSSa). Cognitive function. Accessed April 15, 2012 at: http://www.nationalmssociety.org/about-multiple-sclerosis/what-we-know-about-ms/symptoms/cognitive-dysfunction/index.aspx</span></li> 

            <li><span> Longley W. MS-related dementia: relatively rare and often misunderstood. <i>Brain Impairment</i> 2007; 8: 154−67.</span></li> 

            <li><span> Prakash RS, Snook EM, Lewis JM, <i>et al.</i> Cognitive impairment in relapsing-remitting multiple sclerosis: a meta-analysis. <i>Mult Scler</i> 2008; 14(9): 1250−61.</span></li> 

            <li><span> Forn C, Belenguer A, Parcet-Ibars MA, <i>et al.</i> Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT). <i>J Clin Exp Neuropsychol</i> 2008; 30(7): 789−96.</span></li> 

            <li><span> Halper J. The psychosocial effect of multiple sclerosis: the impact of relapses. <i>J Neurol Sci</i> 2007; 256 Suppl 1: S34−8.</span></li> 

            <li><span> Multiple Sclerosis International Federation (MSIF). Special Focus on Emotions and cognition. <i>MS in Focus</i> 2004; 4.</span></li> 

            <li><span> Beard S, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. <i>Health Technol Assess</i> 2003; 7: 1−111.</span></li> 

            <li><span> Rizzo MA, Hadjimichael OC, Preiningerova J, <i>et al.</i> Prevalence and treatment of spasticity reported by multiple sclerosis patients. <i>Mult Scler</i> 2004; 10(5): 589−95.</span></li> 

            <li><span> Crayton H, Heyman RA, Rossman HS. A multimodal approach to managing the symptoms of multiple sclerosis. <i>Neurology</i> 2004; 63(11 Suppl 5): S12−8.</span></li> 

            <li><span> 
                Rekand T. Clinical assessment and management of spasticity: a review.  <i>Acta Neurol Scand Suppl</i> 2010; (190): 62−6.</span></li> 

            <li><span> Stevenson VL and Marsden JF. What is Spasticity? In: Stevenson V and Jarrett L editors. <i>Spasticity management: a practical multidisciplinary guide</i>. Oxford: Informa Health Care; 2006 p3−14.</span></li> 

            <li><span> Ward AB. A summary of spasticity management – a treatment algorithm. <i>Eur J Neurol</i> 2002; 9(Suppl 1): 48−52. </span></li> 

            <li><span> 
                Nicolson P, Anderson P. The psychosocial impact of spasticity related problems for people with multiple sclerosis: a focus group study. <i>J Health Psychol</i> 2001; 6(5): 551−67.</span></li> 

            <li><span> Porter B. Nursing management of spasticity. <i>Primary Health Care</i> 2001; 11(1): 25–9.</span></li> 

            <li><span> Currie R. Spasticity: a common symptom of multiple sclerosis. <i>Nurs Stand</i> 2001; 15(33): 47−52.</span></li> 

            <li><span> Hirsh AT, Turner AP, Ehde DM, <i>et al.</i> Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors. <i>Arch Phys Med Rehabil</i> 2009; 90(4): 646−51.</span></li> 

            <li><span> O’Connor AB, Schwid SR, Herrmann DN, <i>et al.</i> Pain associated with multiple sclerosis: systematic review and proposed classification. <i>Pain</i> 2008; 137(1): 96−111.</span></li> 

            <li><span> 
                Solaro C, Messmer Uccelli M. Pharmacological management of pain in patients with multiple sclerosis. <i>Drugs</i> 2010; 70(10): 1245−54.</span></li> 

            <li><span> Pardo G, Boutwell C, Conner J, <i>et al.</i> Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate. <i>J Neurosci Nurs</i> 2010; 42(1): 40−6.</span></li> 

            <li><span> Cruccu G, Biasiotta A, Di Rezze S, <i>et al.</i> Trigeminal neuralgia and pain related to multiple sclerosis. <i>Pain</i> 2009; 143(3): 186−91. </span></li> 

            <li><span> National Multiple Sclerosis Society (NMSS). Brochure: Gait or walking problems: the basic facts. Last updated May 2010. Available at: 
                <a href="http://www.nationalmssociety.org/multimedia-library/brochures/managing-specific-issues/index.aspx">http://www.nationalmssociety.org/multimedia-library/brochures/managing-specific-issues/index.aspx</a> (Accessed April 15, 2012).</span></li> 

            <li><span> National Multiple Sclerosis Society (NMSSb). Loss of mobility found to impact quality of life and emotional and financial health of most people living with multiple sclerosis. 
                <a href="http://www.nationalmssociety.org/news/news-detail/index.aspx?nid=199">http://www.nationalmssociety.org/news/news-detail/index.aspx?nid=199</a></span></li> 

            <li><span> Foley F. Psychosocial Impact of Multiple Sclerosis: Challenges and Solutions.<a 
                    href="http://www.medscape.org/neurology"> Medscape Education Neurology & Neurosurgery</a> 2010.</span></li> 

            <li><span> Patten SB, Beck CA, Williams JV, <i>et al.</i> Major depression in multiple sclerosis. A population-based perspective. <i>Neurology</i> 2003; 61(11): 1524−7.</span></li> 

            <li><span> Samuel L, Cavallo P. National Multiple Sclerosis Society. Emotional issues of the person with MS. 2011</span></li> 

            <li><span> McGuigan C, Hutchinson M. Unrecognised symptoms of depression in a community-based population with multiple sclerosis. <i>J Neurol</i> 2006; 253(2): 219−23.</span></li> 

            <li><span> Mohr DC, Hart SL, Fonareva I, <i>et al.</i> Treatment of depression for patients with multiple sclerosis in Neurology clinics. <i>Mult Scler</i> 2006; 12(2): 204−8.</span></li> 

            <li><span> Fruehwald S, Loeffler-Stastka H, Eher R, <i>et al.</i> Depression and quality of life in Multiple Sclerosis. <i>Acta Neurol Scand</i> 2001; 104(5): 257−61.</span></li> 

            <li><span> 
                Göksel Karatepe A, Kaya T,Günaydn R, <i>et al.</i> Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability. <i>Int J Rehabil Res</i> 2011; 34(4): 290−8.</span></li> 

            <li><span> Diehr PH, Derleth AM, McKenna SP, <i>et al.</i> Synchrony of change in depressive symptoms, health status, and quality of life in persons with clinical depression. <i>Health Qual Life Outcomes</i> 2006; 4: 27.</span></li> 

            <li><span> Burgess M. Improving relapse management in multiple sclerosis: a nurse-led model. <i>Br J Neurosci Nurs</i>ing 2011; 7: 441–4.</span></li> 

            <li><span> Tremlett H, Zhao Y, Joseph J, <i>et al.</i> Relapses in multiple sclerosis are age- and time-dependent. <i>J Neurol Neurosurg Psychiatry</i> 2008; 79(12): 1368−74.</span></li> 

            <li><span> Ennis M, Shaw P, Barnes F, <i>et al.</i> Developing and auditing multiple sclerosis relapse management guidelines. <i>Br J Neurosci Nurs</i> 2008;4(6):266−71.</span></li> 

            <li><span> Leone MA, Bonissoni S, Collimedaglia L, <i>et al.</i> Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study. <i>Mult Scler</i> 2008; 14(4): 485−93.</span></li> 

            <li><span> D’hooghe MB, Nagels G, Bissay V, <i>et al.</i> Modifiable factors influencing relapses and disability in multiple sclerosis. <i>Mult Scler</i> 2010; 16(7): 773−85.</span></li> 

            <li><span> Kalb R. The emotional and psychological impact of multiple sclerosis relapses. <i>J Neurol Sci</i> 2007; 256 Suppl 1: S29−33.</span></li> 

                <li><span>
                    Patel Y, Bhise V, Krupp L. Pediatric multiple sclerosis. <i>Ann Indian Acad Neurol</i> 2009; 12(4): 238−45.</span></li> 

                <li><span>Boiko A, Vorobeychik G, Paty D, <i>et al.</i> Early onset multiple sclerosis: A longitudinal study. <i>Neurology</i> 2002; 59(7): 1006−10.</span></li> 

                <li><span>Renoux C, Vukusic S, Mikaeloff Y, <i>et al.</i> Natural history of multiple sclerosis with childhood onset. <i>N Engl J Med</i> 2007; 356(25): 2603−13.</span></li> 

                <li><span>Chitnis T, Glanz B, Jaffin S, <i>et al.</i> Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. <i>Mult Scler</i> 2009; 15(5): 627−31.</span></li> 

                <li><span>Banwell B, Ghezzi A, Bar-Or A, <i>et al.</i> Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. <i>Lancet Neurol</i> 2007; 6(10): 887−902.</span></li> 

                <li><span>Krupp L. Racial and ethnic findings in pediatric MS: An update. <i>Neurology</i> 2008; S70: A135.</span></li> 

                <li><span>Deryck O, Ketelaer P, Dubois B. Clinical characteristics and long term prognosis in early onset multiple sclerosis. <i>J Neurol</i> 2006; 253(6): 720−3.</span></li> 

                <li><span>Mikaeloff Y, Caridade G, Assi S, <i>et al.</i> Prognostic factors for early severity in a childhood multiple sclerosis cohort. <i>Pediatrics</i> 2006; 118(3): 1133−9.</span></li> 

                <li><span>
                    Ghezzi A. Childhood-juvenile multiple sclerosis: clinical characteristics and treatment. <i>Expert Rev Neurother</i> 2005; 5(3): 403−11.</span></li> 

                <li><span>MacAllister WS, Boyd JR, Holland NJ, <i>et al.</i> The psychosocial consequences of pediatric multiple sclerosis. <i>Neurology</i> 2007; 68(Suppl. 2): S66−9.</span></li> 

                <li><span>Banwell BL. Pediatric multiple sclerosis. <i>Curr Neurol Neurosci Rep</i> 2004; 4(3): 245−52.</span></li> 

                <li><span>Kis B, Rumberg B, Berlit P. Clinical characteristics of patients with late-onset multiple sclerosis. <i>J Neurol</i> 2008; 255(5): 697−702.</span></li> 

                <li><span>Martinelli V, Rodegher M, Moiola L, <i>et al.</i> Late onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis. <i>Neurol Sci</i> 2004; 25 Suppl 4: S350−5.</span></li> 

                <li><span>Abe M, Tsuchiya K, Kurosa Y, <i>et al.</i> Multiple sclerosis with very late onset: a report of a case with onset at age 82 years and review of the literature. <i>J Spinal Disord</i> 2000; 13(6): 545–9.</span></li> 

                <li><span>Tremlett H, Devonshire V. Is late onset multiple sclerosis associated with a worse outcome? <i>Neurology</i> 2006; 67(6): 954–9.</span></li> 

                <li><span>
                    Bove RM, Healy B, Augustine A, <i>et al.</i> Effect of gender on late-onset multiple sclerosis. <i>Mult Scler</i> 2012 Mar 1. [Epub ahead of print]</span></li> 

                <li><span>Burgess M.  Multiple Sclerosis: Theory and Practice for Nurses. Whurr Publishing 2002.</span></li> 

                <li><span>Thornton IL, Rizzo JF, Cestari DM. Neuromyelitis optica: a review. <i>Semin Ophthalmol</i> 2011; 26(4-5): 337−41</span></li> 

                <li><span>Brøonnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. <i>Brain </i> 2004; 127(Pt 4): 844–50.</span></li> 

                <li><span>Grytten Torkildsen N, Lie SA, Aarseth JH, <i>et al.</i> Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. <i>Mult Scler</i> 2008; 14(9): 1191–8.</span></li> 

                <li><span>Ragonese P, Aridon P, Salemi G, <i>et al.</i> Mortality in multiple sclerosis: a review. <i>Eur J Neurol</i> 2008; 15(2): 123–7.</span></li> 

                <li><span>Vukusic S, Confavreux C. Natural history of multiple sclerosis: risk factors and prognostic indicators. <i>Curr Opin Neurol</i> 2007; 20(3): 269−74.</span></li> 

                <li><span>Bergamaschi R. Prognostic factors in multiple sclerosis. <i>Int Rev Neurobiol</i> 2007; 79: 423−47.</span></li> 

                <li><span>Tremlett H, Zhao Y, Rieckmann P, <i>et al.</i> New perspectives in the natural history of multiple sclerosis. <i>Neurology</i> 2010; 74(24); 2004−15</span></li> 

                <li><span>Degenhardt A, Ramagopalan SV, Scalfari A, <i>et al.</i> Clinical prognostic factors in multiple sclerosis: a natural history review. <i>Nat Rev Neurol</i> 2009; 5(12): 672−82.</span></li> 

                <li><span>Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. <i>Brain </i> 2003; 126 (Pt 4): 770−82.</span></li> 

                <li><span>Debouverie M, Pittion-Vouyovitch S, Louis S, <i>et al.</i> Natural history of multiple sclerosis in a population based cohort. <i>Eur J Neurol</i> 2008; 15(9): 916–21.</span></li> 

                <li><span>Mohr DC, Hart SL, Julian L, <i>et al.</i> 
                    <Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. <i>BMJ</i> 2004; 328(7442): 731.</span></li> 

                <li><span>Artemiadis AK, Anagnostouli MC, Alexopoulos EC. 
                    Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. <i>Neuroepidemiology</i> 2011; 36(2): 109−20.</span></li> 

        </ul>
        </div>
    </div>
</asp:Content>

